Senior Director, Patient & Professional Advocacy

How will your role help us transform hope into reality?

The Senior Director of Patient and Professional Advocacy will lead a unified strategy to connect patient advocacy and professional engagement for systemic mastocytosis (SM) and related mast cell diseases, with a strong focus on driving impactful initiatives to support the SM launch within the United States (U.S.). This role will cultivate strong relationships with key patient organizations, professional stakeholders, and institutions to advance awareness, advocacy, and patient care for these rare conditions.

This leader will ensure patient insights are integrated into organizational strategies across R&D, Medical Affairs, U.S. Commercial, Corporate Affairs, and other functions, with a particular emphasis on supporting SM-related initiatives.

This position serves as a key advocacy liaison with professional societies, fostering collaboration between advocates and healthcare providers to raise awareness, encourage meaningful dialogue, and deliver innovative solutions that enhance patient care. The Senior Director will design and execute strategic engagement initiatives across therapeutic areas, ensuring alignment throughout the medicine development lifecycle, with a special focus on launch readiness and patient-centered outcomes for SM.

You will work as a collaborative member of the cross-functional team to bring the patient experience and perspective into development, trial planning & recruitment, and product launch. In partnership with the Patient Affairs Team, you will engage directly with the patient community to ensure their voices shape key decisions, meet critical education and advocacy needs, and enhance access to vital information for those affected by cancer and mast cell diseases.

Additionally, this role will integrate the insights and contributions of opinion leaders, patient advocacy groups, and professional societies into evidence generation, global advisory efforts, and strategic initiatives across medical affairs functions.

What will you do?

Strategic Leadership and Planning

• Design and implement a strategy to integrate patient advocacy and professional engagement for systemic mastocytosis (SM) and related mast cell diseases, building partnerships with professional societies, healthcare providers, and key advocates to drive shared initiatives in disease awareness, education, and patient support, with a specific emphasis on supporting non-promotional SM launch efforts by prioritizing disease education, patient advocacy, and professional engagement.
• Develop and lead a cross-functional annual plan to gather unfiltered patient insights through advisory boards and other research efforts with patients, advocates, and influencers.
• Drive the amplification of the voice of patients, influencing cross-functional teams to bring forward the patient voice in a tangible way aligned with our core value of "patient first."
• Develop metrics to measure the success of advocacy initiatives, ensuring alignment with organizational goals.
• Manage budgets and resources for advocacy-related programs to maximize efficiency and community impact.
• Stay informed of emerging trends and opportunities in advocacy, adapting strategies to meet evolving needs.
• Ability to travel up to 30%, including domestic and international travel.

Patient-Centered Advocacy and Insights

• Integrate the patient voice across all stages of drug development and launch planning to ensure therapies address real-world needs, with a key focus on SM.
• Partner with clinical research teams to ensure patient priorities are reflected in the development of meaningful clinical endpoints and outcomes, leveraging insights from patient advocacy groups, advisory boards, and real-world experiences to shape trial design and evidence generation.
• Act as a patient advocacy representative to ensure patient perspectives and needs are integrated into research, development, and strategic planning efforts.
• Integrate patient insights into development and commercialization efforts by recommending actionable, evidence-based strategies across teams and executing initiatives within the advocacy function to drive patient-centered decision-making, advance disease education, and enhance advocacy outcomes.
• Collaborate with Health Economics and Outcomes Research (HEOR) teams to integrate patient insights into evidence generation and strategic initiatives, ensuring SM-focused outcomes are prioritized.

Professional Advocacy and Collaboration

• Create and execute a comprehensive engagement strategy with healthcare providers (HCPs), professional societies, and institutions to advance patient advocacy within their communities.
• Build partnerships that drive collaborative advocacy efforts, such as APSHO initiatives on disease control and patient-centered care.
• Work closely with Medical Affairs to align on strategic priorities and support joint advocacy efforts.

Community Engagement and Representation

• Design and implement initiatives that align patient and professional communities throughout the medicine development lifecycle, including clinical trial planning, recruitment, product launches, and educational programs.
• Represent the organization at advocacy forums, professional conferences, and community events to drive visibility and engagement.
• Perform other responsibilities as assigned

What minimum qualifications do we require?

• Bachelors Degree in public health, nursing, life sciences, communications, or a related field
• 10+ years of experience in patient advocacy or equivalent experience in the pharmaceutical/biotech sector

What additional qualifications will make you a stronger candidate?

• Demonstrated success in navigating regulatory and legal compliance related to advocacy efforts.
• Deep understanding of commercialization and R&D, including experience with commercial product launches.
• Proven Leadership in Cross-Functional Teams
• Experience in allergy/immunology other rare disease or oncology experience.
• Excellent communication, collaboration, and leadership skills to effectively engage cross-functional teams, patients, and external stakeholders.
• Agile, strategic leader adept at navigating fast-paced environments, shifting priorities, and ambiguity to drive patient-centered impact and measurable outcomes.
• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law. We are also an E-Verify Employer. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com.

For more information, please see ourEEO-AA Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and/or theEEO Know Your Rights Poster, as well as ourPay Transparency Statement.

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.

#LI-Hybrid